tiprankstipranks
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Holding DE:XRP2?
Track your performance easily

Silence Therapeutics (XRP2) Ownership - Who Owns Silence Therapeutics?

6 Followers

Silence Therapeutics (XRP2) Ownership Overview

6.10%0.15%47.22%0.14%46.39%
6.10%
Insiders
47.22% Other Institutional Investors
0.14% ETFs
46.39% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (DE:XRP2) stock is a mix of institutional, retail, and individual investors. Approximately 47.51% of the company’s stock is owned by Institutional Investors, 6.10% is owned by Insiders, and 46.39% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$1726378

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,495,310Insider6.10%112,826,212
406,903Institution0.87%5,404,079
387,400Institution0.83%5,145,059
52,132Institution0.11%692,365
34,893Institution0.07%463,414
29,417Institution0.06%390,687
8,077Institution0.02%107,271
4,674Institution0.01%62,075
4,238Institution<0.01%56,285

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
34,893Institution0.07%463,414
29,417Institution0.06%390,687
4,238Institution<0.01%56,285

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Silence Therapeutics (DE:XRP2)?
According to the latest TipRanks data, approximately 47.22% of the company's stock is held by institutional investors, 6.10% is held by insiders, and 46.39% is held by retail investors.
    What percentage of Silence Therapeutics (DE:XRP2) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 47.22% of Silence Therapeutics (DE:XRP2) stock is held by institutional investors.
      What percentage of Silence Therapeutics (DE:XRP2) stock is held by retail investors?
      According to the latest TipRanks data, approximately 46.39% of Silence Therapeutics (DE:XRP2) stock is held by retail investors.
        Who owns the most shares of Silence Therapeutics (DE:XRP2)?
        Raymond Debbane owns the most shares of Silence Therapeutics (DE:XRP2).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis